Style | Citing Format |
---|---|
MLA | Hosseinzadeh L, et al.. "Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects." Research in Pharmaceutical Sciences, vol. 12, no. 4, 2017, pp. 290-298. |
APA | Hosseinzadeh L, Aliabadi A, Rahnama M, Sadeghi HMM, Khajouei MR (2017). Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects. Research in Pharmaceutical Sciences, 12(4), 290-298. |
Chicago | Hosseinzadeh L, Aliabadi A, Rahnama M, Sadeghi HMM, Khajouei MR. "Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects." Research in Pharmaceutical Sciences 12, no. 4 (2017): 290-298. |
Harvard | Hosseinzadeh L et al. (2017) 'Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects', Research in Pharmaceutical Sciences, 12(4), pp. 290-298. |
Vancouver | Hosseinzadeh L, Aliabadi A, Rahnama M, Sadeghi HMM, Khajouei MR. Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects. Research in Pharmaceutical Sciences. 2017;12(4):290-298. |
BibTex | @article{ author = {Hosseinzadeh L and Aliabadi A and Rahnama M and Sadeghi HMM and Khajouei MR}, title = {Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects}, journal = {Research in Pharmaceutical Sciences}, volume = {12}, number = {4}, pages = {290-298}, year = {2017} } |
RIS | TY - JOUR AU - Hosseinzadeh L AU - Aliabadi A AU - Rahnama M AU - Sadeghi HMM AU - Khajouei MR TI - Synthesis and Cytotoxic Evaluation of Some New 3-(2-(2-Phenylthiazol-4-Yl) Ethyl)-Quinazolin-4(3H) One Derivatives With Potential Anticancer Effects JO - Research in Pharmaceutical Sciences VL - 12 IS - 4 SP - 290 EP - 298 PY - 2017 ER - |